Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

330.34

+11.49 (3.60%)

At close: Apr 6, 2026, 4:00 PM EDT

320.61

-9.73 (-2.95%)

After-hours: Apr 6, 2026, 7:56 PM EDT

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	43,811	52,639	30,424	24,078	29,451	20,380
Market Cap Growth	33.53%	73.02%	26.36%	-18.24%	44.51%	34.68%
Enterprise Value	43,871	50,964	28,984	22,903	28,537	18,902
Last Close Price	330.34	397.65	235.31	191.41	237.65	169.58
PE Ratio	141.78	170.67	-107.94	-54.38	-25.55	-23.55
Forward PE	50.35	60.03	-	-	-	-
PS Ratio	11.80	14.17	13.53	13.17	28.39	24.14
PB Ratio	55.41	66.70	453.50	-109.13	-186.13	34.65
P/TBV Ratio	55.88	67.86	447.73	-108.36	-182.78	34.15
P/FCF Ratio	94.14	113.11	-714.37	574.04	-48.02	-28.38
P/OCF Ratio	83.60	100.44	-3660.27	231.17	-54.41	-31.76
EV/Sales Ratio	11.81	13.72	12.89	12.53	27.51	22.39
EV/EBITDA Ratio	78.73	91.46	-241.10	-100.40	-38.53	-28.59
EV/EBIT Ratio	87.47	101.61	-163.86	-81.16	-36.35	-26.67
EV/FCF Ratio	94.27	109.51	-680.55	546.02	-46.53	-26.32
Debt / Equity Ratio	1.56	1.56	18.69	-5.73	-8.08	1.63
Debt / EBITDA Ratio	2.29	2.29	-10.78	-5.72	-1.78	-1.51
Debt / FCF Ratio	2.75	2.75	-30.43	31.12	-2.15	-1.39
Net Debt / Equity Ratio	-2.07	-2.07	-20.84	5.14	5.51	-2.44
Net Debt / EBITDA Ratio	-2.92	-2.92	11.63	4.97	1.18	2.17
Net Debt / FCF Ratio	-3.50	-3.50	32.84	-27.03	1.42	2.00
Asset Turnover	0.81	0.81	0.56	0.50	0.29	0.24
Inventory Turnover	8.46	8.46	3.86	2.85	1.57	1.73
Quick Ratio	2.51	2.51	2.61	2.86	3.16	3.79
Current Ratio	2.76	2.76	2.78	3.08	3.51	4.04
Return on Equity (ROE)	55.79%	73.28%	362.29%	232.40%	-526.14%	-106.31%
Return on Assets (ROA)	10.58%	10.58%	-3.23%	-7.77%	-21.92%	-20.12%
Return on Invested Capital (ROIC)	63.85%	63.85%	-20.29%	-43.01%	-108.72%	-76.10%
Return on Capital Employed (ROCE)	15.31%	15.31%	-5.98%	-10.01%	-27.42%	-24.57%
Earnings Yield	0.72%	0.59%	-0.93%	-1.84%	-3.91%	-4.25%
FCF Yield	1.06%	0.88%	-0.14%	0.17%	-2.08%	-3.52%
Buyback Yield / Dilution	-5.51%	-5.51%	-2.20%	-2.64%	-2.73%	-3.01%
Total Shareholder Return	-5.51%	-5.51%	-2.20%	-2.64%	-2.73%	-3.01%

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q